ITGAM and neoplasm: Flow cytometric analysis of the tumor‐infiltrated immune cells revealed an increased CD4+ cells, CD4+Pd1+ cells, a reduced CD11b+F4/80+ macrophages, and a trend of increased CD8+ cells, CD8+Ifnγ+ cells, CD8+Pd1+ cells, CD4+Ifnγ+ cells, and B cells in FIN56‐treated tumors (Figure 6C).